CLRs consist of a family of one type of transmembrane pattern recognition receptors (PRRs) that recognize glycosylated pathogen-associated molecular patterns (PAMPs) or glycoantigens expressed on tumour cells, among others [114,115,116,117]. The gene discussed is LARS1; the disease is neoplasm.